Safety and efficacy of G2-S16 dendrimer as microbicide in healthy human vaginal tissue explants.

J Nanobiotechnology · 2022 · PMC8935742 · PMID 35307031

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

No significant differences were observed either on CD8 + or CD4 + activation, however, a slight trend could be observed on CD4 + population (Fig. 4 , lower panels), suggesting the biosafety of G2-S16 dendrimer and diminishing possible side effects.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.